Literature DB >> 7149715

Accessory replicons of species of Salmonella and Shigella.

T S Dhillon, Y W Hui, C H Teoh-Chan, E K Dhillon.   

Abstract

Shigella and Salmonella strains isolated from clinical samples were examined. Out of 42 Shigella strains tested, 17 (40%) were found to be colicinogenic and another 3 were lysogenic. All three lysogens yielded a phage antigenically homologous to coliphage P2. Out of 30 strains tested, only 1 was found to be resistant to both neomycin and sulfamethoxazole. Out of 48 strains of Salmonella tested for drug resistance, only 2 showed multiple drug resistance. In contrast to Shigella isolates, the Salmonella isolates were infrequently (approximately 5%) bacteriocinogenic. The frequency of lysogeny in Salmonella strains was found to be 6% when tested on Salmonella typhimurium LT2, but by using a set of five indicators belonging to species Salmonella potsdam, Salmonella mbadanka, Salmonella dublin, Salmonella london, and Salmonella wandsworth, 50% of the strains were shown to be lysogenic. Salmonella phages related to P22 were recoverable from Salmonella saintpaul, Salmonella indiana, and Salmonella heidelberg. Some isolates of S. typhimurium yielded a temperature-sensitive and P22-heterologous phage which was found to be a more efficient transducer of bacterial genetic markers than P22. EcoRI-generated fragments of the DNA of some phages permitted the establishment of a clonal descent for some of the wild-type lysogenic bacterial strains. This last observation points out the potential usefulness of prophages as epidemiological markers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149715      PMCID: PMC242104          DOI: 10.1128/aem.44.4.825-831.1982

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  15 in total

1.  EcoRI analysis of bacteriophage P22 DNA packaging.

Authors:  E N Jackson; D A Jackson; R J Deans
Journal:  J Mol Biol       Date:  1978-01-25       Impact factor: 5.469

2.  HK239: a P2 related temperate phage which excludes rII mutants of T4.

Authors:  E K Dhillon; T S Dhillon
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

3.  Analysis of endonuclease R-EcoRI fragments of DNA from lambdoid bacteriophages and other viruses by agarose-gel electrophoresis.

Authors:  R B Helling; H M Goodman; H W Boyer
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

4.  Abortive induction of bacteriophage P2.

Authors:  L E Bertani
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

Review 5.  The ecology of transferable drug resistance in the enterobacteria.

Authors:  E S Anderson
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

6.  Mutants of phage HK239 defective in excluding phages lambda T4rII, P1, and P2.

Authors:  T S Dhillon; E K Dhillon
Journal:  Mol Gen Genet       Date:  1973-12-31

7.  Studies on bacteriophage distribution: virulent and temperate bacteriophage content of mammalian feces.

Authors:  T S Dhillon; E K Dhillon; H C Chau; W K Li; A H Tsang
Journal:  Appl Environ Microbiol       Date:  1976-07       Impact factor: 4.792

8.  Temperate coliphages: classification and correlation with habitats.

Authors:  E K Dhillon; T S Dhillon; Y Y Lam; A H Tsang
Journal:  Appl Environ Microbiol       Date:  1980-05       Impact factor: 4.792

9.  Coliphage HK243: biological and physicochemical characteristics.

Authors:  T S Dhillon; E K Dhillon; S Toyama; S Linn
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

10.  Incidence of lysogeny, colicinogeny, and drug resistance in enterobacteria isolated from sewage and from rectum of humans and some domesticated species.

Authors:  T S Dhillon; E K Dhillon
Journal:  Appl Environ Microbiol       Date:  1981-04       Impact factor: 4.792

View more
  1 in total

1.  Temperate coliphage HK253: attachment site and restricted transduction of proAB mutants of Escherichia coli K-12.

Authors:  A P Poon; T S Dhillon
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.